Mannitol

甘露醇

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameMannitol
Drug Alias Name甘露糖醇OsmitrolBronchitolAridolE421
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationPainDisease Progression +[23] 
Global Approved IndicationsOcular HypertensionIntracranial HypertensionBrain Edema +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[30] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPharmaxis Europe LtdNtc SrlUniversitas Diponegoro +[5] 
Inactive CompaniesThe Brigham and Women's HospitalUniversity Of RochesterSyntara Ltd +[13] 
Active IndicationsOcular HypertensionIntracranial HypertensionBrain Injuries, Traumatic +[9] 
Inactive IndicationsRejection of renal transplantationPainDisease Progression +[14] 

Other Information

ATC CodeA06AD16B05BC01B05CX04 +[5] 
Related LinksWikipediaDrugBankKEGG